Itolizumab

Patanjali Anti-Allopathy Ad, a Window Into All That’s Wrong With Our Healthcare

COVID-19: India Has a Habit of Bad Clinical Trials

Dr Reddy’s Revealed More About 2-DG, and Its Approval Is More Confusing Now

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us

India’s Drug Regulator Has Approved DRDO’s New COVID Drug on Missing Evidence

DCGI Approves Virafin for Moderate COVID. Where’s the Evidence It Works?

Have You Tested Positive For COVID-19? This is What Happens Next.